Cancer Medicine: Major shock to cancer patients and their families. Now Cancer medicine prices to rise in upcoming days. In response to increasing pressure on the country’s cancer treatment system, the central government has sanctioned a price increase for several essential chemotherapy drugs. This decision arrives at a moment when hospitals and cancer treatment centers nationwide are facing a critical shortage of life-saving medications such as Cisplatin and Carboplatin. The government is optimistic that this price adjustment will enable drug manufacturers to boost production and enhance market supply.
As per report, the Department of Pharmaceuticals sent a letter to the Member Secretary of the National Pharmaceuticals Pricing Authority (NPPA) on June 7. The letter stated, “The Hon’ble Minister (Chemicals and Fertilizers) has granted in-principle approval for the application of Para 19 of the DPCO, 2013 for these medications.
The price adjustment was authorized under Paragraph 19, a special provision that permits the government to step in outside the usual price-control framework when it considers it necessary to guarantee the availability or affordability of vital medicines.
What led to the Cancer Drug crisis?
In recent months, the supply of cisplatin and carboplatin has been consistently decreasing across the country. These platinum-based chemotherapy drugs are commonly used to treat various cancers, including lung, cervical, ovarian, head and neck, and bladder cancers. Medical professionals indicate that these drugs provide limited alternatives, and in many instances, they represent the most effective component of treatment.
Which medicines did the government provide relief to?
According to the report, pharmaceutical companies had requested price revisions for approximately 82 drugs. Following inter-ministerial consultations, price increases have currently been approved for four critical drugs, including cancer treatment drugs. The government’s goal is to make production economically viable and increase market availability.
Several major hospitals and cancer centers in the country have expressed concern about drug shortages. Doctors say that in some cases, patients are having to postpone therapy or adjust dosages to prolong available supplies. Experts say that if this crisis continues, the treatment of thousands of patients could be affected.
